Glen Eagle Advisors, LLC Tg Therapeutics, Inc. Transaction History

Glen Eagle Advisors, LLC

  • $546 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$13.32 - $19.19 $1,332 - $1,919
-100 Closed
0 $0
Q4 2018

Aug 13, 2024
SELL
$3.44 - $5.76 $344 - $576
-100 Closed
0 $0
Q1 2018

Aug 14, 2024
BUY
$8.7 - $16.8 $869 - $1,680
100 New
100 $1.42 Million
Q3 2017

Aug 13, 2024
BUY
$10.0 - $12.7 $1,000 - $1,270
100 New
100 $1.19 Million
Q2 2017

Aug 12, 2024
BUY
N/A
100
100 $1.01 Million

Others Institutions Holding TGTX

# of Institutions
299
Shares Held
91.9M
Call Options Held
1.9M
Put Options Held
1.45M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $3.65B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email